# Neurobiology of Bulimia Nervosa

> **NCT04225221** · PHASE2 · COMPLETED · sponsor: **University of North Carolina, Chapel Hill** · enrollment: 10 (actual)

## Conditions studied

- Bulimia Nervosa

## Interventions

- **DRUG:** Estradiol
- **DRUG:** Micronized progesterone
- **DRUG:** Leuprolide Acetate
- **DRUG:** Placebo Oral Capsule

## Key facts

- **NCT ID:** NCT04225221
- **Lead sponsor:** University of North Carolina, Chapel Hill
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-02-24
- **Primary completion:** 2022-04-04
- **Final completion:** 2022-04-04
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2022-07-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04225221

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04225221, "Neurobiology of Bulimia Nervosa". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04225221. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*